What is Omnipod®?
Tubeless: Forget the tubes of traditional insulin pumps.
Wearable: Place the Pod almost anywhere you’d normally inject insulin.
Waterproof‡: Wear your Pod in the shower, swimming pool or sea!
Each wearable Pod gives you up to three days (72 hours) of continuous insulin delivery, avoiding the inconvenience and interruptions of up to 14 injections* per Pod.
You’re in control with personalised insulin doses, delivered in just a few finger taps via the Pod’s handheld companion, while the built-in Bolus Calculator takes the headache out of mealtime maths.
Simplify diabetes management with Omnipod!
*Average number of injections required every 3 days (MDI:~4.5perday). Data on file.
In a survey, 97% of Omnipod® users in the US said that they would recommend it to a friend
Unlock the Power of Pod Therapy
Meet our tubeless, wearable Omnipod lineup
Meet the Omnipod 5
Omnipod 5 is the first and only tubeless automated insulin delivery system that works with the leading sensor brands*.
Compatible with the Dexcom G6 sensor or the FreeStyle Libre 2 Plus sensor, Omnipod 5 makes automated† basal insulin adjustments every five minutes based on sensor readings, to help keep you in range while lowering HbA1c1,2.
And there’s so much more to Omnipod 5 that can help you to level up your life!
- SmartAdjust™ technology automatically increases, decreases, or pauses insulin every 5 minutes, based on your customised target—helping to protect against highs and lows1,2, day and night. Share the load with the system that never sleeps.
- Activity feature, when enabled, reduces insulin delivery when glucose typically goes low, for example when exercising, so you can sweat without stress.
- SmartBolus Calculator, the only built-in bolus calculator that automatically incorporates your sensor value and trend, so you don’t have to.
Say hello to Omnipod DASH
Simplify Life™ with Omnipod DASH. Place the Pod on your body almost anywhere you would inject insulin for up to three days (72 hours) of continuous insulin delivery.
The Personal Diabetes Manager (PDM) communicates wirelessly with the Pod, so you can adjust your insulin doses discreetly and easily wherever you are, without the need for tubing.
Say yes to life with Omnipod DASH and discover life, uninterrupted!
We believe in freedom of choice!
At Insulet, we believe those who have been deemed eligible for pump therapy should have the freedom to choose and the flexibility to change insulin delivery devices with no ‘lock-in’ periods.
Are you new to pump therapy, or considering switching to a different insulin pump? Find out more about how our commitment to choice may help you.
The Omnipod® has really given me the quality of life, it changed my lifestyle and I already can see an improvement in my Diabetes management.
Kelly Rowe
Podder® since 2018
Order your free sample Pod* today!
The Pod Experience Kit (PEK*) is a real-size, real-weight dummy Pod, without the insulin. It’s designed to give you an idea of what it feels like to wear a Pod, and get a sense of how discreet it can be.
† Bolus for meals and corrections are still needed.
1. Study in 240 people with T1D aged 6 - 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Average A1c in adults/adolescents and children, standard therapy vs. Omnipod 5 = 7.16% vs 6.78%; 7.67% vs 6.99%. Brown S. et al. Diabetes Care (2021).
2. Study in 80 people with T1D aged 2 - 5.9 yrs involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose (>180mg/dL) from CGM in standard therapy vs Omnipod 5 = 39.4% vs. 29.5%. Average time with low blood glucose (<70mg/dL) from CGM in standard therapy vs Omnipod 5 = 3.41% vs. 2.13%.Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Sherr JL, et al. Diabetes Care (2022).